Litcius/Paper detail

CAR T cells for multiple sclerosis: Engineering T cells to disrupt chronic B cell–driven neuroinflammation

Daniel Ortuño‐Sahagún, Cristina Hermosillo‐Abundis, María Paulina Reyes-Mata, Óscar Arias-Carrión

2025Multiple Sclerosis and Related Disorders7 citationsDOI

Topics & Concepts

MedicineNeuroinflammationMultiple sclerosisChimeric antigen receptorNeuromyelitis opticaImmunologyDemyelinating DisorderExperimental autoimmune encephalomyelitisImmune systemCell therapyCentral nervous systemT cellEncephalomyelitisCytokine release syndromeCAR T-cell therapyCD19Progressive multifocal leukoencephalopathyClinical trialImmunotherapyAutoimmunityAutoimmune encephalitisNeuroscienceAdoptive cell transferMyelinAlemtuzumabAntigenMyelin oligodendrocyte glycoproteinMicrogliaOligodendrocyteSpectrum disorderCAR-T cell therapy researchCRISPR and Genetic EngineeringViral Infectious Diseases and Gene Expression in Insects
CAR T cells for multiple sclerosis: Engineering T cells to disrupt chronic B cell–driven neuroinflammation | Litcius